• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axogen, Inc. - Common Stock (NQ:AXGN)

32.67 +1.62 (+5.22%)
Streaming Delayed Price Updated: 11:14 AM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 390,608
Open 31.73
Bid (Size) 32.66 (200)
Ask (Size) 32.86 (600)
Prev. Close 31.05
Today's Range 31.48 - 33.72
52wk Range 9.215 - 34.24
Shares Outstanding 41,397,053
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
December 17, 2025
From Axogen, Inc.
Via GlobeNewswire
News headline image
Gapping stocks in Thursday's session ↗
December 04, 2025
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill

Performance

YTD
+5.4%
+5.4%
1 Month
+6.1%
+6.1%
3 Month
+93.3%
+93.3%
6 Month
+184.6%
+184.6%
1 Year
+124.4%
+124.4%

More News

Read More
News headline image
AXGN Stock Rises Pre-Market After FDA Approves Nerve Repair Graft ↗
December 04, 2025
Via Stocktwits
Topics Government
News headline image
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)
December 03, 2025
From Axogen, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For October 29, 2025 ↗
October 29, 2025
Via Benzinga
News headline image
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
November 04, 2025
From Axogen, Inc.
Via GlobeNewswire
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
October 29, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
October 29, 2025
Via Benzinga
News headline image
Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday ↗
October 29, 2025
Via Benzinga
News headline image
Axogen Inc (NASDAQ:AXGN) Surges on Strong Q3 2025 Earnings Beat and Raised Guidance ↗
October 29, 2025
Via Chartmill
Topics Earnings
News headline image
Axogen, Inc. Reports Third Quarter 2025 Financial Results
October 29, 2025
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025
October 15, 2025
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – AXGN
October 01, 2025
From DJS Law Group
Via Business Wire
News headline image
AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm
October 01, 2025
From The Schall Law Firm
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
September 24, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
September 14, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
September 10, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
September 06, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
August 27, 2025
From Axogen, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
August 25, 2025
Via Benzinga
News headline image
Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday ↗
August 25, 2025
Via Benzinga
News headline image
FDA Pushes Back Axogen Avance Nerve Graft Decision By 3 Months ↗
August 25, 2025
Via Benzinga
News headline image
Why Axogen Stock, Up 76% Over The Last Two Months, Just Plummeted ↗
August 25, 2025
Via Investor's Business Daily
News headline image
Which stocks are moving before the opening bell on Monday? ↗
August 25, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
August 25, 2025
Via Benzinga

Frequently Asked Questions

Is Axogen, Inc. - Common Stock publicly traded?
Yes, Axogen, Inc. - Common Stock is publicly traded.
What exchange does Axogen, Inc. - Common Stock trade on?
Axogen, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Axogen, Inc. - Common Stock?
The ticker symbol for Axogen, Inc. - Common Stock is AXGN on the Nasdaq Stock Market
What is the current price of Axogen, Inc. - Common Stock?
The current price of Axogen, Inc. - Common Stock is 32.67
When was Axogen, Inc. - Common Stock last traded?
The last trade of Axogen, Inc. - Common Stock was at 01/07/26 11:14 AM ET
What is the market capitalization of Axogen, Inc. - Common Stock?
The market capitalization of Axogen, Inc. - Common Stock is 1.35B
How many shares of Axogen, Inc. - Common Stock are outstanding?
Axogen, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap